Pregled bibliografske jedinice broj: 1257733
Diaminocyclopentane-derived <i>O</i>-GlcNAcase inhibitors for combating tau hyperphosphorylation in Alzheimer's disease
Diaminocyclopentane-derived O-GlcNAcase inhibitors for combating tau hyperphosphorylation in Alzheimer's disease // Chemical Communications, 58 (2022), 63; 8838-8841 doi:10.1039/d2cc02712g (međunarodna recenzija, članak, znanstveni)
CROSBI ID: 1257733 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Diaminocyclopentane-derived <i>O</i>-GlcNAcase
inhibitors for combating tau hyperphosphorylation
in Alzheimer's disease
Autori
Weber, Patrick ; Mészáros, Zuzana ; Jagečić, Denis ; Hribljan, Valentina ; Mitrečić, Dinko ; Bojarová, Pavla ; Slámová, Kristýna ; Vrba, Jiří ; Kulik, Natalia ; Křen, Vladimír ; Stütz, Arnold E.
Izvornik
Chemical Communications (1359-7345) 58
(2022), 63;
8838-8841
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni
Ključne riječi
Alzheimer, tau, O-GlcNAcase inhibitors
Sažetak
We developed potent and selective aminocyclopentane- derived inhibitors of human O-N- acetyl-β-D- glucosaminidase (OGA) implicated in Alzheimer's disease. For example compound 13 was a nanomolar OGA inhibitor with 92 000-fold selectivity over human HexB. It was non-toxic and increased protein O- GlcNAcylation in the culture of murine neural cells, showing new alternatives in the treatment of tauopathies.
Izvorni jezik
Engleski
Znanstvena područja
Temeljne medicinske znanosti, Biotehnologija u biomedicini (prirodno područje, biomedicina i zdravstvo, biotehničko područje)
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE
- Nature Index